The Alluminox™ platform is an investigational platform based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and team from the National Cancer Institute in the United States. Rakuten Medical is currently developing the Alluminox™ platform as a technology consisting of an investigational drug, device and other related components.
![Rakuten Medical - To conquer cancer.](https://cdn-ak-scissors.b.st-hatena.com/image/square/530ebd36d41dac1a9a41389af1b6d28d3c77668e/height=288;version=1;width=512/https%3A%2F%2Frakuten-med.com%2Fus%2Fwp-content%2Fuploads%2Fsites%2F6%2F2021%2F02%2FRakutenMedical_KV.png)